SCHEMBL2320097

SCHEMBL2320097

CC(=O)c1c(-c2cccc(F)c2)noc1C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 2/20 0.47
TRPM8 Q7Z2W7 1/20 0.40
HTR7 P34969 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
GABRA5 P31644 4/20 0.40
GAA P10253 2/20 0.40
TSHR P16473 1/20 0.40
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PTGS2 P35354 2/20 0.38
FFAR4 Q5NUL3 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2321949 0.85 KMT2A (0.54) GABRA5GAATSHRESR1ESR2
SCHEMBL2320437 0.84 GPBAR1 (0.43) GPBAR1HTR7RXFP1GABRA5GAA
SCHEMBL2320102 0.83 PTGS2 (0.53) GPBAR1GABRA5GAAESR1ESR2
SCHEMBL2471876 0.82 GPBAR1 (0.62) GPBAR1GABRA5GAATSHRMEN1
SCHEMBL2319344 0.77 GPBAR1 (0.51) GPBAR1RXFP1ESR1ESR2PTGS2
SCHEMBL27918170 0.75 GPBAR1 (0.63) GPBAR1GABRA5GAATSHRMEN1
SCHEMBL4594713 0.74 GPBAR1 (0.62) GPBAR1GABRA5GAATSHRMEN1
SCHEMBL2319092 0.73 ESR1 (0.56) GABRA5GAATSHRESR1ESR2
SCHEMBL13733599 0.71 LMNA (0.49) GPBAR1HTR7GAATSHRMEN1
SCHEMBL13734171 0.71 GPBAR1 (0.58) GPBAR1GABRA5GAATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170873-B1 ISOXAZOLE-IMIDAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-08-10 EP disclosed
US-7851469-B2 Isoxazole-imidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-12-14 US disclosed
EP-2170873-A1 ISOXAZOLE-IMIDAZOLE DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-04-07 EP disclosed
US-20090005370-A1 ISOXAZOLE-IMIDAZOLE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-01-01 US disclosed
WO-2009000662-A1 ISOXAZOLE-IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005370-A1 ISOXAZOLE-IMIDAZOLE DERIVATIVES GABRA5, GABRA1, GABRA4 GPBAR1 177/4885TRPM8 2120/4885HTR7 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.